[1] A. Bjo ̈rklund, O. Lindvall, Dopamine-containing systems in the
CNS, in: A. Bjo ̈rklund, O. Lindvall (Eds.), Handbook of Chemical
Neuroanatomy. Classical Transmitters in the CNS, Part 1, Vol. 2,
Elsevier, Amsterdam, 1984, pp. 55–122. [22]
[2] H. Braak, E. Braak, D. Yilmazer, C. Schultz, R.A.I. De Vos, E.N.H.
Jansen, Nigral and extranigral pathology in Parkinson's disease, J.
Neural. Transm. 46 (1995) 15–31. [23]
[3] D.J. Brooks, Morphological and functional imaging studies on the
diagnosis and progression of Parkinson's disease, J. Neurol. 247
(Suppl. 2) (2000) 11–18.
[4] D.J. Brooks, V. Ibanez, G.V. Sawle, N. Quinn, A.J. Lees, C.J. [24]
18
Mathias et al., Differing patterns of striatal F-dopa uptake in
Parkinson's disease, multiple system atrophy, and progressive [25]
supranuclear palsy, Ann. Neurol. 285 (1990) 47–55.
[5] D.J. Brooks, E.D. Playford, V. Ibanez, P.D. Thompson, L.J. Findley,
C.D. Marsden, The association between isolated tremor and disrup-18
tion of the nigro-striatal dopaminergic system, studied with F-dopa [26]
and PET, Neurology 42 (1992) 1554–1560.
[6] W.D. Brown, M.D. Taylor, A.D. Roberts, T.R. Oakes, M.J. Schueller, J.E. Holden et al., Fluoro DOPA PET shows the nondopaminer- [27]
